Wyatt R J, Apud J A, Potkin S
Neuropsychiatry Branch, NIMH Neuroscience Center, St. Elizabeth's Hospital, Washington DC 20032, USA.
Psychiatry. 1996 Winter;59(4):357-70. doi: 10.1080/00332747.1996.11024774.
Our current treatments for schizophrenia are, at best, palliative. With the exception of counseling those families with a known high risk for having schizophrenic offspring, no preventive measures are currently available. The not too distant future, however, promises to bring improvements in somatic treatments as well as the possible introduction of preventive measures. We are fully aware that current biological treatments work best when they are combined with psychosocial intervention, and expect that future biological treatments and preventions will also involve appropriate nonbiological considerations. Psychosocial treatments are covered elsewhere in this issue. Here we look at how modern genetics, pre- and perinatal factors, early and sustained intervention, and new medications are likely to decrease both the number of individuals with schizophrenia and the severity of the illness.
